Contents

Recent Patents on CNS Drug Discovery (Discontinued), Volume 9 - Number 2

Patents on Potential Drugs to Treat Alzheimer’s Disease: Special Emphasis on Small Peptides

, 9(2): 71 - 75

Pazhani Sundaram, Aravind K. Nambiar and Ranjini K. Sundaram


DOI: 10.2174/1574889809666140919123006




Possible Physiopathological Effects of the Transglutaminase Activity on the Molecular Mechanisms Responsible for Human Neurodegenerative Diseases

, 9(2): 76 - 84

Martina Iannaccone, Federica Titta, Enrica Serretiello, Marco Monfregola and Vittorio Gentile


DOI: 10.2174/1574889809666141111160124




Pharmacological Approaches to Targeting Muscarinic Acetylcholine Receptors

, 9(2): 85 - 100

Carlo Matera and Ada M. Tata


DOI: 10.2174/1574889809666141120131238




Possible Physiopathological Roles of the Transglutaminase Activity in the Etiopathogenesis of Human Neurodegenerative Diseases

, 9(2): 101 - 109

Federica Titta, Martina Iannaccone, Antonio Martin and Vittorio Gentile


DOI: 10.2174/1574889809666140613114850




Advancing Drug Therapy for Brain Tumours: A Current Review of the Pro-inflammatory Peptide Substance P and its Antagonists as Anti-cancer Agents

, 9(2): 110 - 121

Kimberley Mander, Elizabeth Harford-Wright, Kate M. Lewis and Robert Vink


DOI: 10.2174/1574889809666141111142740




Recent Patents on Novel MCH1 Receptor Antagonists as Potential Anti-Obesity Drugs

, 9(2): 122 - 140

Katalin K. Szalai, Gyula Beke, Janos Eles, Tamas Kitka, Peter Kovacs, Jozsef Nagy, Sandor Farkas and Andras Boros


DOI: 10.2174/1574889809666140613115426




Patent Selections:

, 9(2): 141 - 151


DOI: 10.2174/157488980902141209160802




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science